Tufts CSDD Demonstrates Multi-Million-Dollar Benefits of Translational Pharmaceutics®
6 / 57 articles displayed
Awards
Quotient Sciences has won the Deal of the Year award at the 2019 Medilink East Midlands Business Awards. The Deal of the Year award recognises entrepreneurship of an individual or team in executing a truly transformational and high-value deal for both the company and the East Midlands Life Sciences sector
News
Quotient Sciences, the innovative drug development and manufacturing organization, today announces the appointment of Claes Glassell as non‐executive chairman of its board of directors. A highly accomplished leader in the pharmaceutical industry with over 35 years’ experience, Glassell has held numerous leadership positions, including at the board level, to help companies through high phases of growth.
News
Quotient Sciences to Recapitalize With Global Private Equity Firm Permira
News
Quotient’s Andy Lewis appointed as Secretary of Controlled Release Society
Awards
Quotient Sciences has won the Outstanding Achievement Award at the 2019 Medilink UK Healthcare Business Awards.
Awards
Quotient Sciences announced that it has received a Transatlantic Growth Award at a ceremony hosted by BritishAmerican Business in London. The award, in the 'UK SME in the US' category, was presented to Gordon Cameron, CFO, Quotient Sciences.
Ask us a question
